MET and breast cancer: Similarly, we also found that patient brain metastases from basal triple-negative breast cancer exhibited more c-Met/β1 complex by proximity-ligation assays (PLAs) than brain metastases from luminal A, ER+PR+HER2– breast cancer (P = 0.02; Supplemental Figure 5).